Please use this identifier to cite or link to this item:
https://doi.org/10.1186/s13756-016-0149-9
Title: | Core components for effective infection prevention and control programmes: New WHO evidence-based recommendations | Authors: | Storr, J Twyman, A Zingg, W |
Keywords: | acute health care facility antibiotic resistance Article evidence based practice good clinical practice hand washing health care facility health insurance health program healthcare associated infection hospital bed utilization infection control infection prevention national health service patient preference personnel management point of care system practice guideline priority journal program effectiveness workload world health organization |
Issue Date: | 2017 | Citation: | Storr, J, Twyman, A, Zingg, W (2017). Core components for effective infection prevention and control programmes: New WHO evidence-based recommendations. Antimicrobial Resistance and Infection Control 6 (1) : 6. ScholarBank@NUS Repository. https://doi.org/10.1186/s13756-016-0149-9 | Rights: | Attribution 4.0 International | Abstract: | Health care-associated infections (HAI) are a major public health problem with a significant impact on morbidity, mortality and quality of life. They represent also an important economic burden to health systems worldwide. However, a large proportion of HAI are preventable through effective infection prevention and control (IPC) measures. Improvements in IPC at the national and facility level are critical for the successful containment of antimicrobial resistance and the prevention of HAI, including outbreaks of highly transmissible diseases through high quality care within the context of universal health coverage. Given the limited availability of IPC evidence-based guidance and standards, the World Health Organization (WHO) decided to prioritize the development of global recommendations on the core components of effective IPC programmes both at the national and acute health care facility level, based on systematic literature reviews and expert consensus. The aim of the guideline development process was to identify the evidence and evaluate its quality, consider patient values and preferences, resource implications, and the feasibility and acceptability of the recommendations. As a result, 11 recommendations and three good practice statements are presented here, including a summary of the supporting evidence, and form the substance of a new WHO IPC guideline. © 2017 World Health Organization. | Source Title: | Antimicrobial Resistance and Infection Control | URI: | https://scholarbank.nus.edu.sg/handle/10635/178711 | ISSN: | 20472994 | DOI: | 10.1186/s13756-016-0149-9 | Rights: | Attribution 4.0 International |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1186_s13756-016-0149-9.pdf | 554.25 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License